Acalabrutinib–Venetoclax improves progression-free survival and reduces disease progression in untreated chronic lymphocytic ...

Scientists at the Garvan Institute of Medical Research have discovered that certain gene variations associated with leukemia ...

Changes in Blood Cell Production Over the Lifetime Could Impact Leukemia Outcomes Dec. 5, 2024 — The first comprehensive map of the dramatic changes that take place in the blood system over the ...

Inc. (Market cap: $34.46M) has reported its financial performance for the fourth quarter of 2023, highlighting a steady cash flow and strategic advancements in its clinical pipeline. According to ...

Acute Myeloid Leukemia (AML) is a hematological malignancy characterized by the rapid, uncontrolled growth of immature myeloid cells, leading to bone marrow ...

T-cell therapy represents a groundbreaking advancement in the field of immuno-oncology. This innovative treatment involves ...

Despite the established links between inflammation and cancer development, the effects of inflammatory signaling on cancer ...

First of many site approvals, including sites in the US, Europe and the Middle East, expected throughout Q1-Q3 2025 Company remains on track for first subject treated in pivotal, adaptive Phase 3 ...

PLC ("TC BioPharm" or the "Company")  a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced the first ...

A new study has linked "forever chemicals" in our water to an up to 33% increase in the incidence of some rare cancers.

These drugs, discovered decades ago, continue to save lives today, but more recent research has led to the development of ...

Seven-year-old WA boy Ace was diagnosed with Acute Lymphoblastic Leukemia when he was just five years old. Acute lymphoblastic leukemia (ALL) is a type of blood cancer that occurs when the bone marrow ...